Formycon AG (FYB.DE)

EUR 23.15

(-0.22%)

Total Liabilities Summary of Formycon AG

Formycon AG's latest annual total liabilities in 2023 was 387.61 Million EUR , down -22.03% from previous year.
Formycon AG's latest quarterly total liabilities in 2024 Q2 was 371.47 Million EUR , down 0.0% from previous quarter.
Formycon AG reported annual total liabilities of 497.11 Million EUR in 2022, up 3253.46% from previous year.
Formycon AG reported annual total liabilities of 14.82 Million EUR in 2021, up 96.0% from previous year.
Formycon AG reported quarterly total liabilities of 485.52 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Formycon AG reported quarterly total liabilities of 387.61 Million EUR for 2023 FY, down -22.03% from previous quarter.

Annual Total Liabilities Chart of Formycon AG (2023 - 2009)

Historical Annual Total Liabilities of Formycon AG (2023 - 2009)

Year	Total Liabilities	Total Liabilities Growth
2023	387.61 Million EUR	-22.03%
2022	497.11 Million EUR	3253.46%
2021	14.82 Million EUR	96.0%
2020	7.56 Million EUR	41.51%
2019	5.34 Million EUR	-16.28%
2018	6.38 Million EUR	20.82%
2017	5.28 Million EUR	23.03%
2016	4.29 Million EUR	88.68%
2015	2.27 Million EUR	-30.28%
2014	3.26 Million EUR	2.22%
2013	3.19 Million EUR	-5.48%
2012	3.37 Million EUR	639.5%
2011	457 Thousand EUR	118.4%
2010	209.25 Thousand EUR	243.03%
2009	61 Thousand EUR	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	371.47 Million EUR	0.0%
2023 Q2	485.52 Million EUR	0.0%
2023 FY	387.61 Million EUR	-22.03%
2023 Q4	387.61 Million EUR	0.0%
2022 FY	497.11 Million EUR	3253.46%
2022 Q2	424.96 Million EUR	0.0%
2022 Q4	497.11 Million EUR	0.0%
2021 FY	14.82 Million EUR	96.0%
2021 Q2	12.13 Million EUR	0.0%
2021 Q4	10.26 Million EUR	0.0%
2020 Q2	5.35 Million EUR	0.0%
2020 FY	7.56 Million EUR	41.51%
2020 Q4	7.56 Million EUR	0.0%
2019 FY	5.34 Million EUR	-16.28%
2019 Q2	4.19 Million EUR	0.0%
2019 Q4	5.34 Million EUR	0.0%
2018 FY	6.38 Million EUR	20.82%
2018 Q4	6.38 Million EUR	0.0%
2018 Q2	9.07 Million EUR	0.0%
2017 Q2	3.26 Million EUR	0.0%
2017 FY	5.28 Million EUR	23.03%
2017 Q4	5.28 Million EUR	0.0%
2016 FY	4.29 Million EUR	88.68%
2016 Q2	1.73 Million EUR	0.0%
2016 Q4	4.29 Million EUR	0.0%
2015 Q4	2.27 Million EUR	0.0%
2015 Q2	2.93 Million EUR	0.0%
2015 FY	2.27 Million EUR	-30.28%
2014 Q2	448.75 Thousand EUR	0.0%
2014 Q4	3.26 Million EUR	0.0%
2014 FY	3.26 Million EUR	2.22%
2013 FY	3.19 Million EUR	-5.48%
2013 Q4	3.19 Million EUR	0.0%
2013 Q2	2.89 Million EUR	0.0%
2012 FY	3.37 Million EUR	639.5%
2012 Q4	3.37 Million EUR	0.0%
2012 Q2	5.36 Million EUR	0.0%
2011 FY	457 Thousand EUR	118.4%
2010 FY	209.25 Thousand EUR	243.03%
2009 FY	61 Thousand EUR	0.0%

Peer Total Liabilities Comparison of Formycon AG

Name	Total Liabilities	Total Liabilities Difference
BioNTech SE	2.76 Billion EUR	85.958%
CureVac N.V.	271.53 Million EUR	-42.75%
Biotest Aktiengesellschaft	945.4 Million EUR	59.0%
Biotest Aktiengesellschaft	945.4 Million EUR	59.0%
BRAIN Biotech AG	47.92 Million EUR	-708.82%
Heidelberg Pharma AG	21.01 Million EUR	-1744.604%
Medigene AG	10.65 Million EUR	-3539.54%